Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

Conclusions
Despite a trend favouring the add-on strategy, these data suggest that both tocilizumab add-on and switch strategies led to meaningful clinical and radiographic responses.

Source: Annals of the Rheumatic Diseases - April 4, 2014 Category: Rheumatology Authors: Dougados, M., Kissel, K., Conaghan, P. G., Mola, E. M., Schett, G., Gerli, R., Hansen, M. S., Amital, H., Xavier, R. M., Troum, O., Bernasconi, C., Huizinga, T. W. J. Tags: Open access, Immunology (including allergy), Biological agents, Connective tissue disease, Degenerative joint disease, Drugs: musculoskeletal and joint diseases, Musculoskeletal syndromes, Rheumatoid arthritis Clinical and epidemiological research Source Type: research